However, the decreased concentration of sIFNAR2 found in our study agrees with previous studies describing that the SARS-CoV-2 proteins inhibit the IFN-I pathway (29–31), resulting in a decline of IFN-α and -β among patients with COVID-19 (28, 32). Here, IFNA1 is linked to COVID-19.